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Abstract
Concern is mounting regarding the human health and environmental effects of bisphenol A (BPA),
a high-production-volume chemical used in synthesis of plastics. We have reviewed the growing
literature on effects of low doses of BPA, below 50 mg/kg/day, in laboratory exposures with
mammalian model organisms. Many, but not all, effects of BPA are similar to effects seen in response
to the model estrogens diethylstilbestrol and ethinylestradiol. For most effects, the potency of BPA
is approximately 10 to 1,000-fold less than that of diethylstilbestrol or ethinylestradiol. Based on our
review of the literature, a consensus was reached regarding our level of confidence that particular
outcomes occur in response to low-dose BPA exposure. We are confident that adult exposure to BPA
affects the male reproductive tract, and that long-lasting, organizational effects in response to
developmental exposure to BPA occur in the brain, the male reproductive system, and metabolic
processes. We consider it likely, but requiring further confirmation, that adult exposure to BPA
affects the brain, the female reproductive system, and the immune system, and that developmental
effects occur in the female reproductive system.
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INTRODUCTION
Bisphenol A (BPA) is used as the monomer to manufacture polycarbonate plastic, the resin
that lines most food and beverage cans, dental sealants, and as an additive in other plastics
(Figure 1, Table 1) [1]. BPA is one of the highest volume chemicals produced worldwide;
global BPA production capacity in 2003 was 2.2 million metric tons (over 6.4 billion pounds),
with a 6-10% growth in demand expected per year [2]. Heat and either acidic or basic conditions
accelerate hydrolysis of the ester bond linking BPA monomers, leading to release of BPA and
the potential for human and environmental exposure. Studies conducted in Japan [3] and in the
USA [4] have shown that BPA accounts for the majority of estrogenic activity that leaches
from landfills into the surrounding ecosystem.
BPA has been demonstrated in both in vivo and in vitro experiments to act as an endocrine
disrupting chemical (EDC) (reviewed in [5,6]). There is extensive evidence that BPA is an
estrogen-mimicking chemical, although recent findings have revealed that BPA is a selective
estrogen receptor modulator (SERM), since BPA and the potent endogenous estrogen 17β-
estradiol (E2) do not always show identical effects, and in some studies BPA has been shown
to antagonize the activity of E2 [7]. There is evidence that, similar to other estrogens, BPA can
bind to androgen receptors and inhibit the action of androgen [8]. In addition, there is evidence
for an anti-thyroid hormone effect of BPA [9]. However, effects of BPA mediated by binding
to androgen and thyroid hormone receptors appear to require higher doses than those required
to elicit estrogenic or antiestrogenic responses [7].
Chemicals classified as endocrine disruptors include not only hormone-mimics or antagonists
that act via binding to receptors, but also chemicals that can interfere with hormone synthesis
and clearance, as well as other aspects of tissue metabolism. Experiments have shown that
BPA influences enzyme activity and thus metabolism in various tissues. Another mechanism
of endocrine disruption is the alteration of hormone receptor expression, and experiments
described below have shown that BPA alters hormone receptor numbers and hormone receptor
gene activity in target tissues.
In this review, we summarize the recent literature on low-dose effects of BPA in laboratory
animals. The majority of the studies used rats and mice; only a few used other mammalian
species. We conclude with a series of statements expressing our level of confidence concerning
various effects of BPA in laboratory animals at low doses.
Rationale for experimental design, analysis and reporting criteria
Endocrinology experiments with laboratory animals are particularly vulnerable to confounding
effects. Among other difficulties, treatment effects can be masked by hormonally active
components of feed, water, or caging; and species and strains differ greatly in their sensitivity
to different hormonally active compounds. Therefore, proper reporting of experimental design
is critical to evaluation of studies in the literature. Below, we discuss several of the most
important aspects of experimental design, which we considered when evaluating the studies
discussed in this review.
Animal model—Published results must identify precisely the animal model and supplier
being used. For example, Sprague-Dawley rats from different commercial breeders cannot be
assumed to be the same, since it is an outbred stock. In particular, the outbred Sprague-Dawley
CD rat from Charles River Laboratories [Crl:CD(SD)] has very low sensitivity to exogenous
estrogens, and after more than 50 years of selective breeding by Charles River for large body
size and litter size, it would be inappropriate to identify these rats as just Sprague-Dawley
(Table 2). In contrast to the Crl:CD(SD) rat, male and female CD-1 (ICR) mice are highly
sensitive to exposure to low doses of BPA during development as revealed by over 20 published
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studies (reviewed below) reporting significant effects of low doses of BPA in this outbred
stock. This high sensitivity of the CD-1 mouse to BPA is predicted by the high responsiveness
to positive control estrogens: E2, ethinylestradiol and diethylstilbestrol (DES), as revealed by
both the in vivo studies discussed here and other studies of CD-1 cells and organs in primary
culture [10-12].
The marked difference in sensitivity of different animal models used in toxicological,
pharmacological and endocrinological research is just one of many reasons why it is essential
that experiments include appropriate positive controls, which is discussed in more detail in
following sections. With regard to examination of the in vivo estrogenic activity of BPA, which
is the subject of this review, the sensitivity of the endpoint of interest in the chosen animal
model should be characterized with a positive control such as E2 (appropriate if administration
is by injection or subcutaneous capsule, due to very limited oral absorption of E2) or either
DES or ethinylestradiol (appropriate if chemicals are administered orally, since they are orally
active at very low doses). For example, in the CD-1 mouse, which is the animal model used
by the U.S. National Toxicology Program, an appropriate positive control dose of
ethinylestradiol or DES to detect a response to BPA within the low-dose range (below 50 mg/
kg/day) would be an oral dose not greater than 5 μg/kg/day. This suggestion is based on
numerous reports that for responses mediated by nuclear estrogen receptors, estimates of BPA
potency in CD-1 mice range between 10 – 1,000-fold less than either ethinylestradiol or DES,
depending on the specific response being measured [10,12-16]. Also, doses of DES above 5
μg/kg/day can result in opposite effects relative to lower doses; this has been shown following
developmental exposure for the prostate [16,17] and uterus [18]. High doses of these positive
control estrogenic chemicals are thus not appropriate as a positive control for low-dose effects
of BPA or other estrogenic endocrine disrupting chemicals.
Feed, water, and housing—The exact feed used must be identified. Ideally, the
estrogenicity of the feed should be characterized, since estrogenic components have been
demonstrated to occur in both soy-based and non-soy-based animal feeds. There is also the
possibility of variation in estrogenic activity between different lots of feed commonly used in
toxicological research [19]. If possible, the same lot of feed (same mill date) should be used
throughout an experiment.
The type of caging should be carefully selected to avoid estrogenic contamination of
experimental animals. In particular, polycarbonate cages and water bottles should not be used,
since they will leach uncontrolled concentrations of BPA to the experimental animals [20].
Polypropylene cages have been used successfully in studies of estrogens in mice, and
polysulfone cages are available to replace polycarbonate; polysulfone is a co-polymer
containing BPA and sulfone, but it is reported to be more resistant to degradation at high
temperatures relative to polycarbonate [20]. Similarly, the source of drinking water must be
free of BPA and other estrogens; reverse osmosis and carbon filtration is often necessary to
achieve this requirement. In addition, if BPA is delivered in drinking water, the water must be
free of chlorine or other reactive ions. Adding BPA to chlorinated water results in formation
of tetrachlorobisphenol A.
Method of dosing—In all cases the precise method of dosing the animals and the time of
dosing should be identified. Methods of administration of BPA include: 1. Oral (p.o.): by
gavage, by adding BPA to feed or drinking water, or by feeding the chemical in oil; 2. Injection:
subcutaneous (s.c.), intraperitoneal (i.p.), intracisternal, or intramuscular (i.m.) routes; and 3.
Implantation of Silastic® capsules or Alzet® minipumps that lead to steady-state exposures.
The rationale for the dosing method must also be stated. For example, minipump implants
model continuous exposure and avoid the first-pass metabolism of BPA in the liver that results
from oral exposure.
Richter et al. Page 3
Reprod Toxicol. Author manuscript; available in PMC 2008 August 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
The positive control chosen must be compatible with the selected route of exposure. For
example, E2 has very low activity when administered orally. For studies in which BPA is
administered orally, DES or ethinylestradiol are appropriate positive controls. When BPA is
administered in constant release capsules, E2 would be an appropriate positive control, while
an estrogen agonist with a long half-life would be inappropriate. Route of administration
influences the rate of metabolism of BPA, at least in adults [21], and there is some evidence
for a higher contribution from ingestion of BPA in humans relative to inhalation or absorption
through the skin [22]. However, the report that BPA levels in plasma collected from pregnant
women in Germany show a range encompassing two orders of magnitude, between 0.1 and 10
parts per billion [23], suggests the likely possibility of variable exposure to multiple sources
of BPA. Thus, although oral delivery appears to be most relevant for extrapolation to humans,
all delivery methods may reveal effects of BPA.
Design and Analysis Issues—When animals are assigned to groups, the litter must be
taken into account. It is well established that for both outbred stocks and inbred strains, the
litter is a significant source of variation and needs to be accounted for in assigning animals to
groups. Ideally, one animal per litter should be used. In cases when this is not possible, there
are statistical methods (such as including litter as a main effect variable and dividing the F
value for treatment effects by the F value for litter effects) that can be used when more than
one animal per litter is used, or litter can be used as a covariate in ANCOVA. The method used
to avoid confounding litter effects must be reported.
For all experiments, the positive and negative controls must be clearly identified. Experiments
using a replicate block design should include a positive and a negative control in each block,
if possible. Experiments showing no effect and lacking positive control data cannot be
interpreted.
When taking measurements from adult animals, care must be taken to normalize the
reproductive state of the experimental animals. Males should be singly housed for 2-4 weeks
before collection, in order to avoid physiological differences arising from differences in
dominance status of the males. Normalization of adult female reproductive status can be
achieved by assaying their estrous cycles and collecting females at the same stage, or by using
ovariectomized females with or without hormone replacement [24].
Definition of “Low Dose”
Low-dose effects of environmental endocrine disrupting chemicals generally refer to effects
being reported at doses lower than those used in traditional toxicological studies for risk
assessment purposes. “Low dose” is also commonly used to refer to environmentally relevant
doses, i.e., doses resulting in serum levels close to those observed in human serum. For BPA,
prior to 1997, the lowest dose studied for risk assessment purposes was 50 mg/kg/day, which
in the USA remains the currently accepted lowest observed adverse effect level (LOAEL) that
was used to calculate the current EPA reference dose (and FDA acceptable daily intake or ADI
dose) of 50 μg/kg/day; this presumed “safe” dose is estimated by dividing the LOAEL by three
10-fold safety factors (i.e. by 1000) [25]. Thus, we included in our analysis studies dosing with
less than 50 mg/kg/day BPA (Tables 3 and 4).
Timing of exposure
Exposures to endocrine disruptors have different effects depending on the life stage of the
exposed animals. Effects resulting from adult exposure are generally reversible and are termed
“activational”. Effects resulting from exposure during organ development (beginning during
prenatal development and continuing in postnatal life through puberty) may result in persistent
alterations of the affected systems, even in the absence of subsequent exposure; these effects
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are termed “organizational” [26]. Some organizational effects are measurable immediately
upon exposure and persist throughout the life of the animal [16]. Other organizational effects
are undetectable at the time of exposure, but they become apparent in subsequent adulthood
[26,27]. Windows of vulnerability, also known as critical periods, during which the developing
system is most sensitive to exposure, are common features of organizational effects [28].
Exposures occurring outside the critical periods will not elicit organizational effects. There is
evidence that organizational effects of estrogenic endocrine disruptors such as BPA are
mediated by epigenetic alterations in DNA [29]. Organizational and activational effects on the
same tissue often differ qualitatively as well as in duration and in the dose required to elicit
effects. In this review, we will first discuss organizational effects of prenatal through pubertal
BPA exposure, termed “developmental effects” and then activational effects of adult BPA
exposure, termed “adult effects”.
DEVELOPMENTAL EFFECTS OF BPA DUE TO EXPOSURE DURING
GESTATION THROUGH PUBERTY
Many studies have examined the effects of prenatal, neonatal (shortly after birth) and lactational
(birth through weaning) exposure to low doses of BPA. These experiments involved examining
effects of exposure to low doses of BPA during “critical periods” in the development of
different tissues. These critical periods continue through puberty, the period of physiological
transition to fertility.
Effects on Neurotransmitters and their Receptors, Neuroendocrine Function and Hormone
Receptors in the Brain in Males and Females
A large number of studies have involved examination of the effects of exposure to low doses
of BPA during critical periods in brain development on subsequent brain structure, function
and behavior.
Receptors—Increases in estrogen receptors α (ERα) and β (ERβ) have been observed in
diverse areas of the brain in response to developmental BPA exposure. BPA was administered
to Wistar rats via minipumps at doses of 25 and 250 μg/kg/day from gestation day (GD) 8
through parturition [30]. The male offspring of these mothers were examined, and BPA was
found to permanently up-regulate estrogen receptor 2 (β) (Esr2) mRNA levels in the preoptic
area at 25 μg/kg/day [30]. Female offspring were not examined in this study [30]. Neonatal
[postnatal days (PND) 1-5] injection of Fischer 344 rat pups with a dose of approximately 15
mg BPA/kg/day resulted in increased estrogen receptor 1 (α) (Esr1) mRNA expression in the
medial basal hypothalamus of females, and increased both Esr1 and Esr2 mRNA expression
in the anterior pituitary in males [31]. In Sprague-Dawley rats (Harlan), fed 40 μg BPA/kg/day
at early puberty, from PND 23-30, an increased number of ERα-labelled neurons was found
at puberty (PND 37) in the arcuate nucleus (ARC) in males and females, and in the ventromedial
nucleus (VMH) in females only. At maturity, more ERα-labelled neurons were found in the
medial preoptic area (MPA) in females [32]. Esrl and Esr2 mRNA expression were also
increased in the dorsal raphe nucleus (DRN) of male ICR (CD-1) mice prenatally exposed to
2 μg BPA/kg/day via oral administration to the pregnant female on GD 11 – 17 [33]. In this
study, serotonin, serotonin transporter, and serum testosterone were not altered [33]. BPA
induced changes in somatostatin receptors in the brains of offspring born to Sprague-Dawley
rats that received an oral dose of 400 μg BPA/kg/day during pregnancy and lactation. Exposed
offspring were examined on PND 10 and 23 [34]. BPA also induces increased mRNA
expression of the ligand-activated transcription factors aryl hydrocarbon receptor (AhR),
retinoic acid receptor (RAR) α, and retinoid X receptor (RXR) α in embryonic brain [35,36].
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Neuroendocrine Effects—BPA-induced changes in function of the hypothalamus-
pituitary-gonad axis have been observed in both males and females. In females, disruption of
LH and estrous cyclicity have been reported. The female offspring of Sprague-Dawley rats
exposed during gestation and lactation to approximately 1.2 mg/kg/day of BPA in their drinking
water exhibited disrupted, prolonged estrous cycles and decreased hypersecretion of LH in
response to ovariectomy, suggesting lasting neuroendocrine effects of early BPA treatment
[37]. Disruption of adult estrous cycles seen as an increase in the length of the estrus phase
was also reported to occur in female offspring of pregnant Sprague-Dawley rats administered
BPA orally at a dose of 100 μg/kg/day on GD 6 to 21 [38], and prolonged estrous cycles were
observed in female offspring of CD-1 mice injected with a dose of 500 μg/kg/day BPA on GD
15 to 18 [15]. Exposure via i.m. injection of prepubertal female Poll Dorset lambs to DES
(0.005 mg/kg/day) or BPA (1 mg/kg/day) for 7 weeks beginning at 4 weeks of age (prior to
puberty) had significant effects on LH secretion (a decrease in LH pulse frequency) that were
similar, with the dose of DES being 200-fold lower than BPA [39]. Treatment of pregnant
Suffolk Ewes with 5 mg/kg/day of BPA dissolved in cottonseed oil via daily subcutaneous
injections from GD30-GD60 resulted in marked effects in the female offspring. Levels of LH
were increased during the first two months of postnatal life, breeding season was extended,
and the magnitude of the LH surge was dampened [40].
In males, effects on LH, prolactin, and brain aromatase activity have been observed. Exposure
of weanling males to 2.4 μg/kg/day BPA for 15 days resulted in decreased serum LH and
testosterone levels due to alterations in LH synthesis and secretion at the pituitary level;
neuroendocrine effects in this study were observed following exposure of the weanling mice
to BPA, but not following gestational and lactational exposure [41]. Injecting approximately
15 mg/kg/day of BPA into neonatal Fisher 344 rat pups from postnatal days 1-5 resulted in an
increase in serum prolactin levels (hyperprolactinemia) in both males and females on PND 30
[31]. Male offspring of pregnant and lactating rats exposed to 20 μg/kg/day BPA in drinking
water showed an increase in estrogen synthesis in hippocampal neurons due to an increase in
aromatase activity [42].
BPA exposure also induces alterations in the hypothalamus-pituitary-thyroid axis. Dietary
exposure to doses of 1, 10 or 50 mg/kg/day of BPA in Sprague-Dawley rats from GD 6 through
weaning caused a significant increase in serum total T4 in pups on PND 15, but serum thyroid-
stimulating hormone was not different from controls. The expression of the thyroid hormone-
responsive gene RC3/Neurogranin, measured by in situ hybridization, was significantly up-
regulated by all BPA doses in the dentate gyrus. These findings suggest that BPA acts as an
antagonist of TRβ, which mediates the negative feedback effect of thyroid hormone on the
pituitary gland, but that BPA is less effective at antagonizing TRα, leaving TRα-mediated
events to respond to elevated plasma thyroid hormone levels [9].
Rapid Signaling Effects—BPA has effects similar to E2 (similar potency and efficacy) in
stimulating rapid-response ERK1/2 activity in the cerebellar cortex of Sprague-Dawley rat
pups at PND 5-19; treatment consisted of a 6-min intracerebellar injection followed by rapid
fixation for immunohistochemistical analysis for phosphorylation of ERK1/2. Significant
effects of both BPA and E2 were observed at the lowest dose examined of 1 pM (0.228 ppt).
Interestingly, in addition to acting as an estrogen, when co-administered in conjunction with
E2, BPA was able to inhibit the rapid E2-induced ERK activity in the developing cerebellum,
thus disrupting the action of E2 in a dose-dependent manner [43]. There is another report that
BPA can act as an estrogen antagonist in the hippocampus when BPA is co-administered with
E2 [44].
Brain Structure—Developmental exposure to BPA resulted in a significant change in the
locus coeruleus, where BPA at oral doses of 30 μg/kg/day (in drinking water) and above
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reversed the normal sex differences in this brain structure and eliminated sex differences in
behavior [45,46]. Pregnant and lactating CD-1 mice were exposed to very low doses of BPA,
0.025 and 0.250 μg/kg/day BPA, via Alzet minipumps, and the brain of the offspring were
examined at PND 24-27. The expected robust sex difference in the number of tyrosine
hydroxylase (TH) positive neurons in the sexually dimorphic anteroventral periventricular
preoptic area (AVPV) was apparent in the control offspring. However, in the offspring exposed
to BPA, the sex difference in TH neuron number was undetectable due to a decline in TH
neuron number in BPA exposed females. No significant difference in TH neuron number was
noted in the males [47]. It is interesting to note that injection of much higher doses of BPA
(approximately 300,000-fold higher then the highest daily dose administered to pregnant and
lactating females in the study discussed above, 500 μg/day/pup or approximately 75 mg/kg/
day) directly into rat pups on PND 1 - 2 also altered TH neuron number in the AVPV; however,
the alteration was in a different direction from that reported with very low doses of BPA. With
this much higher dose of BPA, the male offspring showed differences from controls, and the
male AVPV resembled the female AVPV, whereas the females showed no significant effect
of the BPA injection. These data suggest that at this high dose, BPA may have acted as an
antiestrogen and interfered with the masculinization of TH neuron number [48]. The
importance of dose is discussed in more detail below.
In a study with male Wistar rats that received a single intracisternal injection of approximately
20 μg BPA/kg dose on PND 5, BPA reduced the number of dopamine-containing neurons and
resulted in changes in gene expression [49]. A 20 μg/kg/day injection of BPA into pregnant
ICR (CD-1) mice disrupted normal neocortical development in fetuses by accelerating neuronal
differentiation/migration [50].
Behavioral Effects
Aggression—BPA resulted in an increase in defensive aggression in male Sprague-Dawley
rat offspring prenatally exposed to BPA (administered orally to mothers throughout gestation)
at a dose of 40 μg/kg/day; no effect was found in the offspring of mothers treated during
lactation [51]. In addition, increased aggressiveness (using a composite score of aggression)
in male CD-1 mouse offspring occurred as a result of oral administration of 2 μg/kg/day of
BPA to pregnant females on GD 11 - 17 [52].
Activity level and reactivity to stimuli—Treatment of male Wistar rat pups at PND 5
with an intracisternal injection of 0.87 nmol (approximately 20 μg/kg) BPA resulted in
hyperactivity at 4 weeks of age [49,53]. Ishido et al. reported that single intracisternal injections
of approximately 15 μg BPA/kg or 150 μg BPA/kg at PND 5 increased spontaneous motor
activity at 4 weeks of age [54]. Prenatal and lactational exposure to BPA in the feed
(approximately 3 – 300 mg/kg/day) also resulted in an increase in activity with dose and altered
the response to morphine [55]. BPA increased reactivity to painful or fear-provoking stimuli
in the offspring of Sprague-Dawley rats fed 40 μg/kg/day throughout pregnancy and lactation:
a hyperalgesic effect was found following prenatal, but not postnatal exposure [56]. When
pregnant and lactating C57BL/6 mice were administered an oral BPA dose of 2 or 200 μg/kg/
day, BPA increased anxious behavior in a dose-dependent fashion when females were
examined in adulthood. Significant effects were observed in animals exposed to 200 μg/kg/
day of BPA and to 5 μg/kg/day of ethinylestradiol, which was used as a positive control for
the study [57]. In contrast, Farabollini et al. reported that maternal exposure to 40 μg/kg/day
of BPA throughout gestation and lactation resulted in reduced anxiety in adult male offspring,
and lowered motivation to explore in both male and female adult offspring [58].
Learning—BPA impaired learning of both passive and active avoidance tasks in offspring of
Fisher 344 rats fed 100 μg/kg/day of BPA during pregnancy and lactation [59].
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Maternal behavior—Feeding pregnant CD-1 mice 10 μg/kg/day decreased subsequent
maternal behavior in female offspring, similar to behavioral effects seen with adult exposure
[60,61].
Social interactions and response to addictive drugs—Prenatal and lactational oral
exposure of Sprague-Dawley rats to 40 μg/kg/day altered adult play and other socio-sexual
behaviors in both males and females [62,63]. Prenatal and lactational exposure to BPA in the
feed (approximately 3 – 300 mg/kg/day) resulted in an altered response to morphine [55]. The
behavioral response to amphetamine was enhanced in rats and mice at 40 - 300 μg/kg/day
[64,65]. However, at a prenatal dose of 10 μg/kg/day of BPA, exposed adult female CD-1 mice
lost their responsiveness to the reward pathways normally stimulated by amphetamine,
possibly through effects on the dopamine system; in this study there was no effect on male
amphetamine responsiveness, and there was no effect on activity levels [66].
Sexual behavior—An impairment in the timing of copulatory sequence was found in
Sprague-Dawley male rats, perinatally exposed to BPA (40 μg/kg/day fed to the mothers
through gestation or lactation) [51] or treated during early puberty [67]. In animals exposed
via oral administration perinatally, a reduced performance in terms of latency and frequency
of intromission was observed [51]. Effects in the same direction were found with prepubertal
exposure to BPA; this was in agreement with results obtained with the positive control
ethinylestradiol [67].
Sex Differences—One of the most interesting findings concerning organizational effects of
BPA on the brain and behavior and other aspects of physiology is the loss of sex differences
that are typically observed in control males and females. Also intriguing is the effect of BPA
on one sex but not the other [45,46,48,58,66,68-73]. The mechanisms responsible for different
effects of BPA in males and females are not clear, although it is known that BPA metabolism
is influenced by testosterone [74,75], and BPA modifies the metabolism of testosterone [41,
76,77]. Thus, one possibility is that the sex-specific effects of BPA in the brain and other tissues
are due to an interaction with background levels of gonadal steroids. The effects of BPA on
metabolism are discussed in more detail in a companion paper in this issue (see: L. Vandenberg
et al.).
Developmental Effects on the Female Reproductive Tract
Timing of Puberty—Early onset of sexual maturation in females occurred at maternal doses
between 2.4 – 500 μg/kg/day in a number of different mouse strains [13,15,57,78]. Puberty in
female rodents can be assayed by age at vaginal opening or by age at first ovulation, signaling
the onset of fertility. The age at first ovulation can be detected by assessing the age at which
the vaginal epithelium is first cornified, indicating that the female is in estrus, or by pairing
prepubertal females with experienced males and monitoring the females’ age at first parturition.
Timing of puberty is linked to postnatal growth, since puberty is dependent on age, body size,
and energy stores. A study with CF-1 mice showed that the response to prenatal exposure (via
oral dosing of the mother) to a very low dose of BPA (2.4 μg/kg/day) from GD 11-17 was
influenced by the relative position of the fetus with respect to its female and male siblings in
the uterus. The response to BPA was greatest in the females that were located in utero between
female siblings (2F females) in terms of stimulating an increase in postnatal growth and
accelerating the age at first vaginal estrus; postnatal growth was also stimulated in males that
were located in utero between female siblings (2F males) but not in male offspring that were
located in utero between male siblings (2M males). This finding is consistent with the
observation that a very low maternal dose of BPA stimulated a change in the developing
mammary gland in 2F female but not 2M female CD-1 mouse fetuses [79]. Taken together,
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these findings suggest that the endogenous concentrations of E2 and/or testosterone are
significant factors is determining the response to BPA during fetal life in mice.
Mammary Gland—Stimulation of mammary gland development in CD-1 mice was observed
in the offspring of dams exposed to the very low maternal dose of 0.025 and 0.250 μg/kg/day
delivered tonically by an Alzet pump [80]. A significant increase in the percentage of ducts,
terminal ducts, terminal end buds, and alveolar buds was observed in female offspring of BPA-
treated dams at 6 months of age, collected during proestrus. At 6 months of age, the authors
identified terminal end buds as appearing much less bulbous than terminal end buds observed
during puberty. The treatment-induced changes in histo-architecture, coupled with an increased
presence of secretory product within alveoli observed in the BPA-exposed offspring, resembled
those of early pregnancy. Examination of BPA-exposed females (using the same paradigm) at
30 days of age [81] revealed an increase in mammary gland area and number of terminal end
buds, as well as an increase of progesterone receptor-positive ductal epithelial cells that were
localized in clusters, suggesting future branching points. These sites may be involved in the
increase in lateral branching noted in the mammary glands of offspring born to BPA-exposed
dams [80].
The female offspring of pregnant Wistar rats implanted throughout pregnancy with an Alzet
minipump that released 25 μg/kg/day of BPA were examined at various times up to 6 months
of age [82]. At puberty, animals exposed prenatally to BPA showed an increased mammary
gland proliferation/apoptosis ratio both in the epithelial and stromal compartments. BPA
exposed animals showed an increased number of hyperplastic ducts with signs of desmoplasia,
suggesting a heightened risk of neoplastic transformation. Administration of a sub-
carcinogenic dose of N-nitroso-N-methylurea (NMU) to the female rats exposed prenatally to
BPA increased the percentage of hyperplastic ducts and induced the development of neoplastic
lesions. In a related report Wistar-Furth offspring born to mothers implanted with osmotic
minipumps that released BPA at a dose of 2.5 μg/kg/day during gestation and lactation revealed
evidence of ductal hyperplasias at PND 50 and 95 that included increased expression of Ki67
and Esr1. Some of the ductal lesions were identified as carcinoma in situ [83].
The effect of exposure to 0.25 μg/kg/day delivered to CD-1 mice by Alzet minipump from the
evening of gestational day 8 throughout pregnancy was examined in female fetuses on GD 18
[79]. In unexposed fetuses, the mammary gland ductal tree was more developed in 2M females
than in 2F females [79]; this result is counterintuitive, since prior research has shown that 2M
female fetuses have elevated serum testosterone and lower serum E2 relative to the 2F female
siblings [84]. BPA exposure increased mammary gland ductal area and ductal extension and
eliminated intrauterine position differences; this was due to BPA stimulating a significant
change in 2F females but not 2M females [79]. In the stroma, BPA exposure promoted
maturation of the fat pad and altered the localization of collagen. Within the epithelium, BPA
exposure led to a decrease in cell size and delayed lumen formation [79]. Pubertal exposure to
100 μg BPA/kg/day also increased differentiation of mammary gland structures and increased
proliferation of epithelial cells [85].
Uterus and vagina—Oral administration of 100 μg/kg/day or 50 mg/kg/day of BPA to
pregnant Sprague-Dawley rats resulted in a significantly decreased uterine ERβ protein
expression in BPA-treated animals at both doses (relative to controls) when measured during
the estrous phase of the cycle. Interestingly, a high dose of 200 μg/kg/day ethinylestradiol
caused a similar effect [86]. These same doses of BPA and ethinylestradiol caused striking
changes in vaginal morphology during estrus, including a decrease in the thickness of the
epithelial layer [87]. In addition, Western Blot analysis indicated that following exposure to
either dose of BPA, the full-length variant (64 kDa) of Esr1 was not expressed in the vagina
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of female offspring during estrus, whereas during the diestrus stage, Erα protein expression
did not differ from the control group [87].
Studies in the CD-1 mouse have also revealed alterations in the uterus and vagina in offspring
born to mothers treated with 0.025 and 0.25 μg BPA/kg/day via Alzet minipumps [88]. These
alterations include decreased vaginal wet weight, decreased volume of the endometrial lamina
propria and increased protein expression of both ERα and progesterone receptor in the luminal
epithelium and subepithelial stroma of the uterus. Consistent with these effects of BPA, studies
have shown that exposure during early development (via injection on PND 1-5) to very low
doses of DES (0.01 μg/kg/day) alters ERα receptor levels and morphology of the uterus in
CD-1 mice [18].
Ovary, Oocytes and Fertility—Significant disruption of the alignment of chromosomes
during meiosis was observed in developing oocytes due to leaching of BPA from polycarbonate
drinking bottles at doses between 15 - 70 μg/kg/day; this finding leads to the prediction that
exposure to BPA during the time that meiosis is reinitiated by the mid-cycle surge in luteinizing
hormone (LH) can result in an increase in aneuploidy, which is one of the major causes of
spontaneous abortion in humans [89]. As predicted by this finding, there was an increase in
mortality of embryos that occurred at a maternal dose of 25 μg/kg/day [90]. Subsequently, a
defect in meiosis was induced in C57BL/6 mouse embryos by maternal oral or injected BPA
at 20 μg/kg/day by Hunt et al., and the effect was similar to the defect seen in untreated Esr2-
knockout mice [91]. The impact of this effect would not be directly on the in utero exposed
female, but on the embryos produced from her oocytes (F2 generation effect). Implantation of
embryos is not affected at low BPA maternal doses (as low as 10 μg/kg/day), and is significantly
decreased only at a maternal dose of approximately 70 mg/kg/day, which is just above the low-
dose range [92].
Developmental Effects on the Male Reproductive Tract
Serum Testosterone Levels—Male Long-Evans rats born to mothers exposed to 2.4 μg/
kg/day of BPA via feeding, from GD 12 thorough lactation had decreased levels of testicular
testosterone, which was not due to a decline in serum LH levels but was consistent with a
decline in the steroidogenic capacity of Leydig cells in the BPA exposed males [41]. Decreased
serum testosterone in male CD-1 mice also occurred at a maternal dose of 2 μg/kg/day given
on GD 11 - 17 [52]. In Sprague-Dawley (Harlan) male rats, alterations in circulating
testosterone levels were observed after BPA treatment with 40 μg/kg/day at early puberty (PND
23-30): in this study testosterone was reduced in the juveniles (PND 37), and this decrement
persisted in the adults [67].
Prostate—Development of the prostate gland from the urogenital sinus is dependent on
systemic testosterone, which is metabolized to 5α-dihydrotestosterone in the urogenital sinus
mesenchyme. The mesenchyme directs the development of the epithelium into the glandular
structure of the prostate [93]. An increase in adult prostate size in male offspring occurred
when pregnant females were fed BPA at 2 or 20 μg/kg/day on GD 11 - 17 in CF-1 mice [94],
at 10 μg/kg/day on GD 14 - 18 in CD-1 mice [16], and 50 μg/kg/day on GD 16-18 in CD-1
mice [10]; in the experiments conducted by Timms et al. [16] and Gupta [10], DES caused the
same effects as BPA at a maternal oral dose of 0.1 μg DES/kg/day. Gupta [10] also showed
that the effect of BPA on the prostate was directly on prostate tissue by removing the prostatic
region of the fetal urogenital sinus and examining the effect of BPA in organ culture; the lowest
effective concentration (LoEC) of BPA that stimulated an increase in prostate growth was 50
pg/ml (ppt). DES also stimulated prostate growth in primary culture at a dose of 0.5 pg/ml (ppt)
[11]. Richter et al. removed the prostatic region of the fetal urogenital sinus and examined the
prostatic mesenchyme cells, which contain the androgen and estrogen receptors, in primary
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culture. With a constant physiological concentration of 5α-dihydrotestosterone, E2 stimulated
androgen receptor mRNA levels at 1 pM (0.27 pg/ml), while BPA caused the same effect at 1
nM (0.23 ng/ml), which is within the range of BPA detected in human fetal umbilical cord
blood [23]. Maternal exposure to DES (0.1 μg/kg/day, p.o.), an increase in free serum E2 (of
0.1 pg/ml, via Silastic implant) and BPA (50 μg/kg/day, p.o.) all caused a permanent increase
in prostatic androgen receptors in mice in addition to an increase in adult prosate weight,
relative to negative controls [10,16,17].
In addition to effects on prostate size and androgen responsiveness, prenatal exposure to BPA
may affect the development of prostate cancer in later life. Timms et al. [16] observed in GD
19 male CD-1 mouse fetuses that a maternal oral dose of 10 μg BPA/kg/day on GD 14 - 18
stimulated an increase in the number of primary prostatic ducts as well as proliferation of basal
cells (the progenitor cells thought to be responsible for the development of prostate cancer) in
the dorsolateral, but not ventral, primary ducts. This is of interest in that a similar dose of BPA
administered via injection to neonatal rats resulted in 100% of the subsequent adult males
exhibiting prostate interepithelial neoplasia (PIN) lesions, which are pre-tumorous prostate
cancer lesions [29]. Epigenetic changes occurring during development may be the basis for the
adult altered susceptibility to disease [95]. BPA is also implicated as a factor in the disruption
of therapy for human prostate cancer, since BPA can bind and activate a mutant form of the
androgen receptor, T877A, found in some human prostate cancers, and thus stimulate
proliferation of human prostate cancer cells in the absence of androgen [96].
The prostate in rodents is composed of distinct lobes that respond differently to endocrine
disruptors. Differences in cell proliferation and differentiation markers in stromal cells were
observed in ventral prostate following prenatal exposure to 25 μg/kg/day of BPA in prepubertal
Wistar rats [30,97]. This finding is different from those reported by Timms et al. [98], in which
male Sprague-Dawley rats exposed to the highest natural serum levels of E2 (due to developing
between female fetuses [99]) showed enlargement of the dorsolateral prostate but not the
ventral prostate. In another study, prepubertal male Wistar rats were injected with 50 mg BPA/
kg/day between PND 22-32. BPA induced a transient surge in prolactin (implicated in the
regulation of prostate growth) and a subsequent increase in adult prostate size in later adulthood
[100]. On PND 70, prostate weight was significantly increased and daily sperm production
was decreased in Sprague-Dawley rats exposed during gestation via a maternal oral dose of
100 μg/kg/day of BPA [38]. In contrast to these findings, DES (6.5 μg/kg/day) or BPA (30 and
300 μg/kg/day) administered via drinking water to pregnant and lactating Wistar rats did not
induce significant effects on the ventral prostate (the only region examined) [46].
Testes, Epididymis, Sperm and Seminal Vesicles—In contrast to development of the
prostate from the urogenital sinus, development of the epididymis, vas deferens and seminal
vesicles from the Wolffian ducts is dependent on diffusion of testosterone from the testis rather
than systemic testosterone, and does not involve metabolism of testosterone to 5α-
dihydrotestosterone. Thus, drugs and environmental chemicals can have quite different impacts
on differentiation of the Wolffian duct vs. the urogenital sinus [93]. Adult CF-1 male offspring
that had been exposed prenatally to a maternal oral BPA dose of 2 μg/kg/day showed decreased
weights of the epididymis and seminal vesicles, but increased weights of the prostate and
preputial glands; a 20 μg/kg/day dose of BPA resulted in a decrease in daily sperm production
per gram testis [101]. Injection (s.c.) of BPA (50 μg/animal, about 15-20 mg/kg/day) for the
first 5 days after birth resulted in a decrease in the percentage of moving sperm, an increase in
the incidence of malformed sperm, and an increase in the number of ERα-positive cells in the
epididymides of SHN strain mice at 10 weeks of age [102]. Abnormalities in the acrosomal
granule and nucleus of step 2-3 spermatids were also observed in neonatal ICR (CD-1) mice
and Wistar rats injected with 300 μg BPA/kg/day or 1 μg E2/kg/day [103]. Ectoplasmic
specialization between the Sertoli cell and spermatids was also affected, and some
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specializations were partially or totally deleted [103]. Decreased epithelial height in the efferent
ducts of the testes was observed in prepubertal Wistar rats exposed prenatally to 37 mg BPA/
kg/day [104].
Alterations in heat shock proteins in response to BPA were examined in testicular germ cells,
since they are involved in the response to environmental stress and have also been implicated
in developmental events. Hsp90 protein levels were significantly increased at maternal oral
doses of 1 mg/kg/day of BPA and 0.01 μg/kg/day of DES [105]. A finding that contrasts with
those described above occurred when pregnant Sprague-Dawley rats were fed BPA at 0.1 or
50 mg/kg/day. Spermatogenesis was qualitatively normal in all groups, but both doses of BPA
increased testicular weight and Sertoli cell number per organ [106].
Developmental Effects on Metabolism
The earliest reported exposure regime is direct dosing of pre-implantation mouse embryos at
the two-cell stage [107]. In this experiment, development to the eight-cell stage and to the
blastocyst stage was accelerated by exposure to 1 to 3 nM (0.23 – 0.69 ng/ml (ppb)) BPA, and
was delayed by exposure to 100 μM (23 μg/ml) BPA. Both the acceleration and the delay of
development to blastocyst were inhibited by co-treatment with 100 nM tamoxifen, which seems
unexpected since that dose is 1000-fold less than the high BPA concentration. Also, the effects
on embryo development were not seen with E2 over a dose range of 10 fM to 1 μM [107].
When embryos treated with 1 nM BPA were implanted in a female and allowed to develop,
the resulting pup weights at weaning were significantly increased compared to control pups
treated with solvent only (0.1 % ethanol) as embryos [108].
Increased postnatal growth in both male and female rats and mice occurred at maternal doses
between 2.4 – 500 μg/kg/day [15,37,41,78,107,109,110]. Evidence is accumulating that during
critical periods in development, estrogenic chemicals can have unexpected effects on the
differentiation of adipocytes as well as postnatal growth [111]. Newbold et al. reported that
neonatal exposure to a low dose (1 μg/kg/day) of DES stimulated a subsequent increase in
body weight and an increase in body fat in mice [18]. In a related study a high 100 μM dose
of BPA stimulated an increase in the glucose transporter GLUT4 and glucose uptake into 3T3-
F442A adipocytes in cell culture [112]. In a separate study of transgenic mice over expressing
the GLUT4 gene, increased basal and insulin-induced glucose uptake was observed in whole
body and in isolated adipocytes [113]. Whether the mouse 3T3 cell lines, which are relatively
insensitive to estrogen, are an appropriate model to study the effects of BPA in vitro remains
to be determined.
Some studies have found decreased body weight in response to developmental BPA exposures
[13,38,94], and some have found no effects on body weight [54,57,114]. Recent research on
the effect of the type of animal feed used in an experiment on postnatal growth suggests that
whether or not an increase or decrease in body weight occurs may be related to the type of feed
used [115]. In addition, the impact of exposure to BPA during pregnancy and/or lactation on
the maternal behavior and lactational efficiency of mothers cannot be ignored [60,61]. For
example, an experiment by Howdeshell et al., which reported increased body weight in
response to prenatal BPA exposure [78], differed in design from an experiment conducted by
Nagel et al., which reported decreased body weight [94]. Howdeshell cesarean delivered the
pups and fostered them to untreated dams. In contrast, Nagel allowed prenatally treated mice
to nurse their own offspring, leading to an opposite effect on adult body weight. These two
studies used the same low (2 μg/kg/day) maternal dose of BPA, the same CF-1 strain of mice,
and the same type of feed.
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Developmental Effects on the Immune System
There has been only one study of the developmental effects of BPA on immune function.
Prenatal BPA exposure appeared to increase all tested immune responses to soluble antigen in
exposed offspring [116]. Following feeding of DBA/1J mice a 30 μg BPA/kg/day dose from
day 0 through day 17 of gestation, adult male offspring produced increased antigen-specific
IgG2a antibody. A higher prenatal dose of 300 μg/kg/day increased adult production of both
T helper 1 interferon gamma (IFN-γ) and T helper 2 IL-4 cytokines in exposed male and female
offspring [116]. The two cytokines tested have wide-ranging and distinct effects on immune
function; dysregulation of cytokine production could have implications for inflammation or
allergic responses.
EFFECTS OF BPA EXPOSURE DURING ADULTHOOD
BPA exposure at low doses has diverse activational effects. Some of these effects are predicted
due to the affinity of BPA for ERα and ERβ, while other effects diverge from those observed
in response to activation of estrogen receptors.
Adult Effects on the Brain and Behavior
Funabashi et al. [117-119] reported that a single injection of adult ovariectomized female
Wistar rats with BPA at 400 μg/kg - 40 mg/kg increased progesterone receptor protein in the
preoptic area, ventromedial hypothalamus and frontal cortex, as well as progesterone receptor
mRNA in the preoptic area. Specifically, estrogen acts to induce progesterone receptor in the
hypothalamus, and Northern blot analysis revealed an increase in progesterone receptor mRNA
in the preoptic area and anterior pituitary of adult female rats acutely dosed with approximately
35 mg BPA/kg [117]. In this study, BPA caused responses similar to estrogen in the preoptic
area and anterior pituitary, but not in the mediobasal hypothalamus [117]. A single dose of
approximately 35 mg BPA/kg in adult female rats induced progesterone receptors in the frontal
cortex, but repressed progesterone receptor expression in the temporal cortex [119].
Activational effects of BPA in the brain include an increase in ERα-expressing cells in the
medial preoptic area of pregnant and lactating adult females and non-pregnant, cycling adult
female Sprague-Dawley rats at a BPA dose of 40 mg/kg/day administered orally for a period
of 42 days, corresponding to the time from mating to weaning in the pregnant and lactating
group. In contrast, a decrease in ERα-expressing cells was observed in the arcuate nucleus of
pregnant and lactating females but not non-pregnant, cycling females in response to this
treatment [120].
Injection of ovariectomized E2-treated female Sprague-Dawley rats with 40 – 300 μg BPA/
kg/day resulted in a monotonic dose-related inhibition of E2-stimulated increase in
hippocampal synapses, with all doses producing significant effects [44]. Thus, in the
hippocampus, BPA acted to antagonize the action of E2 on synaptogenesis.
BPA induced a significant increase in serum prolactin levels in 8-10 week old ovariectomized
Fisher 344 rats when administered at a low dose of 40-45 μg/kg/day of BPA for a period of 3
days via Silastic capsules. In contrast, Sprague-Dawley rats were relatively insensitive to both
BPA and E2 in this experiment, which was the first report that the model animal was an
important factor in BPA studies [121].
Exposure of adult female Sprague-Dawley rats from the day of mating through lactation to 40
μg/kg/day of BPA via feeding resulted in alterations in maternal behavior towards their young;
specifically, grooming was reduced in BPA-exposed dams [61]. In Mongolian gerbils (Charles
River, Italy), exposure to pairs of adult males and females via feeding (in oil) 2 or 20 μg BPA/
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kg/day for 3 weeks increased their social interactions and reduced their exploratory behavior;
similar effects were observed in response to 0.04 μg/kg/day of ethinylestradiol [122].
Adult Effects on the Female Reproductive Tract
Acute exposure of C57BL/6 female mice to 20 through 100 μg/kg/day of BPA resulted in a
significant increase in meiotic abnormalities in the oocytes when exposure occurred during the
peri-pubertal period, suggesting that BPA exposure would lead to aneuploidy; this abnormality
was also observed in mice that were housed in polycarbonate cages and that were provided
water in polycarbonate bottles that had been damaged by exposure to a harsh detergent during
washing [89]. The effect of BPA on aneuploidy has also been examined in cell culture
[123-126].
Adult Effects on the Male Reproductive Tract
A decrease in daily sperm production and fertility in male Sprague-Dawley rats was reported
at oral doses between 20 – 200,000 μg/kg/day due to adult exposure, and maximum suppression
of sperm production occurred at 20 μg/kg/day. At doses below 20 μg/kg/day, daily sperm
production was not significantly different from controls [127]. This suggests that there is a
sub-population of cells that are impacted by BPA, and an approximately 40% decrease in daily
sperm production is the maximum that occurs, regardless of the dose of BPA administered
above 20 μg/kg/day. This finding is similar to data reported for prenatal exposure to
ethinylestradiol, where maximum suppression of daily sperm production occurred at 2 ng/kg/
day, with no further suppression occurring at higher doses [128].
Similar to the findings in rats, oral exposure of adult Swiss mice for one month to 25 and 100
μg/kg/day resulted in a decrease in daily sperm production and epididymidal sperm
concentration, which was associated with a decrease in fertility. A dose of 5 μg/kg/day also
resulted in a decrease in the weight of the testes and seminal vesicles [129] (Note that the doses
were incorrectly reported in the paper as ng/kg/day instead of μg/kg/day.) A dose of 20 μg/kg
body weight of BPA was injected (s.c.) to adult ICR (CD-1) mice and Wistar rats for 6 days,
and abnormalities were observed in the spermatids: acrosomal vesicles, acrosomal caps,
acrosomes and nuclei of the spermatids were severely deformed. The ectoplasmic
specialization between the Sertoli cell and spermatids was also affected: incomplete
specialization, redundant ectopic specialization, and aplasia were observed [130]. A significant
decrease in testis and epididymidal weight was also reported to occur in adult male Wistar rats
exposed orally for 45 days to 0.2, 2 and 20 μg/kg/day, while an increase in ventral prostate
weight occurred at all doses [131,132].
Successive i.p. administration of BPA to adolescent male C57BL/6 mice at a dose of 20 mg/
kg/day for 4 weeks decreased the prostate and seminal vesicle weights (but not testis or
epididymis weights) and also decreased serum testosterone and both liver and kidney weights
[133].
BPA at concentrations of approximately 0.2 and 20 mg/kg/day was administered in the drinking
water to young male C57BL/6 mice for eight weeks beginning at 3 weeks of age (before the
onset of puberty), and the number of ERβ-containing cells and Esr2 mRNA per testis were
significantly decreased in the 20 mg BPA/kg/day treated group compared with controls. In
contrast, ERα-immunopositive cells and Esr1 mRNA per testis were markedly increased in
these males relative to controls [134].
An s.c. injection for two weeks of 3 mg/kg/day dose of BPA significantly reduced testicular
testosterone content, and serum testosterone, while plasma LH showed an increase in adult
male Wistar rats [135]. Injection (i.p.) of BPA at a dose of 20 mg/kg/day for 4 weeks decreased
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the prostate and seminal vesicle weights but not the testis or epididymis weights, and also
decreased serum testosterone and both liver and kidney weight in Wistar rats [136]. Plasma
free testosterone levels were dramatically decreased following 8 weeks of 12 mg/kg/day of
BPA treatment of adult male C57BL/6 male mice compared with control group, and
morphologically abnormal multinucleated giant cells having greater than three nuclei were
found in seminiferous tubules in the testis following 8-week BPA treatment at 120 μg/kg/day,
while no controls showed this [133].
Adult Effects on Metabolism
There is considerable experimental evidence that in adult mice E2 acts via ERα to have an
inhibitory effect on adipocyte number and lipogenesis, and removal of estrogen by ovariectomy
or ERα via a genetic mutation also causes impaired glucose tolerance and insulin resistance in
addition to increased fat mass [137,138]. Estrogen has central effects on food consumption and
energy expenditure that also contribute to its overall inhibitory effects on adipose deposition
in adults. BPA has also been reported to decrease body weight in adults [129,139]. These
findings thus contrast numerous reports that low-dose BPA or DES exposure during early
development stimulates postnatal growth.
Very low doses of BPA stimulated rapid secretion of insulin in mouse pancreatic β cells in
primary culture through a non-classical, non-genomic rapid estrogen-response system. In the
same study prolonged exposure to a low oral dose of BPA (10 μg/kg/day) resulted in stimulation
of insulin secretion in adult mice that was mediated by the classical nuclear estrogen receptors;
the prolonged hypersecretion of insulin was followed by insulin resistance [140].
Other effects on metabolic pathways have also been observed in response to BPA. A decrease
in antioxidant enzymes occurred at the very low dose of 0.2 μg/kg/day of BPA in adult Wistar
rat males [131], and at a higher dose of 50 mg/kg/day in ICR (CD-1) male mice [141]. In adult
Wistar rats, oral administration of 1 mg/kg/day of BPA reduced in adult males but not females
the expression of UGT2B1 and other UGT isoforms that mediate the glucuronidation of BPA
and sex hormones [69].
Adult Effects on the Immune System
BPA has been reported to modulate immune function at doses between 2.5 - 30 μg/kg/day
[142,143], including patterns of cytokine and antibody production, response to infection, and
autoimmune disease progression. T helper lymphocytes are a source of cytokine families that
stimulate inflammatory responses and resistance to intracellular infections (Th1 cytokines), or
that shift the response to antibody production, resistance to extracellular organisms, and allergy
(Th2 cytokines). Antigen-specific IFN-γ (Th1) secretion was increased in adult DBA1/J mice
given 30 μg/kg/day BPA p.o. for 20 days and sacrificed 24 hr later [143]. In contrast, a shorter
term oral dose of 2.5 μg/kg/day BPA given PND 35-42 to C57BL/6 and autoimmune-prone
NZB/WF1 mice significantly decreased the production of IFN-γ by splenocytes stimulated
with 4 μg/mL of the T lymphocyte mitogen ConA, up to five weeks post treatment [142]. A
single oral dose of approximately 9 mg BPA/kg just prior to infection with the parasite
Trichinella spiralis increased production of both IL-4 and IL-10 by lymph node cells stimulated
with parasite antigen [144]. Addition of BPA at doses ranging from 0.1 to 30 μM to cultures
of lymphocytes from Leishmania major-infected BALB/c or C57BL/6 mice did not increase
IFN-γ production [144]. Other studies also report an increase in the Th2-associated cytokine,
IL-4, following BPA exposure. Injection (i.p.) of 25 mg/kg/day BPA every other day for one
week in adult KLH-primed BALB/c mice resulted in significant increase of IL-4 production
in CD4+ T cells and of serum antigen-specific immunoglobulin E (IgE) levels [145]. Antigen
specific spleen cells of adult BPA-exposed DBA1/J mice (300 μg/kg/day p.o. for 20 days)
produced an elevated IL-4 response [143]. Thus, most models indicate that BPA may enhance
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or shift the pattern of cytokine production following antigen stimulation. Skewing of the Th1/
Th2 cytokine profile by EDCs has been associated with allergy and asthma [146].
Exposure to BPA has also been associated with modulation of innate immune system cell
function. For example, administration of 5 mg/kg/day s.c. to adult BALB/c mice for 5 days
decreased innate host defense to bacterial infection. Upon challenge with i.p. E. coli injection,
both neutrophil phagocytosis and IL-6 production were significantly reduced [147].
Autoimmune diseases, particularly those mediated by an antibody response to host tissues, are
more common in females; estrogens and prolactin are believed to act as drivers for differential
disease development and progression in individuals with an underlying genetic susceptibility
to autoimmunity. However, BPA exposure modulates the course of glomerulonephritis in the
NZB/WF1 mouse model of systemic lupus erythematosus. An oral dose of 2.5 μg/kg/day given
on PND 35-42 to female NZB/WF1 mice decreased the production of IgG2a antibody by
splenocytes and delayed the onset of glomerulonephritis as measured by albuminuria [142].
Yurino et al. used Silastic implants to administer BPA, E2, or DES to ovariectomized, 4 week
old, female NZB/WF1 mice [148]. Serum concentrations of 30 ng/ml BPA were measured 4
months after implantation. At five months of age, both DES- and E2-treated mice showed an
increase in IgG anti-DNA antibody and prominent deposition of immune complexes in the
glomeruli, both indicators of disease. In contrast, although BPA, DES, and E2 increased IgM-
class autoantibodies, there was no evidence of glomerular immune complex deposition and no
increase in serum anti-DNA IgG antibody in the BPA-exposed mice.
In summary, while it is well accepted that estrogen alters immune function, the interaction is
complex [149]. Estrogen has been reported to both decrease and increase immune function,
depending on dose, including conflicting reports on the production of the T helper 1 cytokine,
IFN-γ [150,151]. The effects of BPA exposure on the immune system may be critically
dependent on the timing of BPA exposure. Estrogen receptor expression by lymphocytes is
dependent upon the age and strain of the animal; in addition, recent evidence suggests the
spleen undergoes significant molecular remodeling during puberty, resulting in both age and
gender-dependent differences in immune gene expression [152]. Nevertheless, studies
conducted by Yoshino et al. [116,143] indicate similar dose-associated, gender-independent
immune system effects in 8 week old offspring of BPA-exposed dams and animals exposed as
adults. These results suggest quantitative, rather than qualitative, differences in lifestage-
dependent immune system sensitivity to BPA.
COMPARISON OF FINDINGS OF SIGNIFICANT EFFECTS AND NO-
SIGNIFICANT EFFECTS IN LOW-DOSE BPA STUDIES
As of the end of October 2006 we are aware of 27 in vivo studies reporting no significant effects
in response to low doses of BPA. The variables that account for most of the studies that find
no significant effects have recently been reviewed [5,153]. Below we discuss a number of these
variables.
Strain Differences
The major factor that accounts for 13 studies that draw the conclusion of no effect of low doses
of BPA is the use of a strain of rat sold by Charles River Laboratories, referred to as the CD-
SD rat [Crl:CD(SD)] (Table 2). According to Charles River [154], rats were purchased by
Charles River from Sprague-Dawley in 1950. This colony was continuously subjected to
selective breeding for rapid postnatal growth and large litter size for over 40 years. The Crl:CD
(SD) rat strain is insensitive to BPA, and 0 of 13 studies report low dose effects [155-167]. In
addition, this rat strain is insensitive to the drug ethinylestradiol at doses (~0.5 μg/kg/day) used
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in oral contraceptives [163,167]. As shown above, a large number of studies show that
significant low-dose effects of BPA have been observed in the original Sprague-Dawley rat.
However, a number of studies have reported that the inbred Fisher 344 rat is more sensitive to
low dose effects of BPA relative to the original Sprague-Dawley rat [121,168,169]. Wistar rats
also appear to be more sensitive than Sprague-Dawley rats to the uterotrophic effects of BPA
[168,170]. One assessment of the uterotrophic response of immature Sprague-Dawley rats
revealed a response following 3 days of exposure to 300 mg/kg/day of BPA. In the same study,
a significant response to ethinylestradiol was noted at 0.3 ug/kg/day [171]. Why the Sprague-
Dawley rat does not respond to low doses of BPA in the uterotrophic bioassay or in the vaginal
stimulation bioassay has been investigated, and the lack of responsiveness appears to be due
to factors after binding to estrogen receptors [169].
The importance of the strain of animal used in low-dose research was acknowledged in the
2001 Low Dose National Toxicology Program (NTP) report. The NTP panel emphasized the
need to test for the sensitivity of any animal model by including a positive control, such as the
well characterized estrogenic drugs DES or ethinylestradiol, and stated [172] p vii): “Because
of clear species and strain differences in sensitivity, animal model selection should be based
on responsiveness to endocrine active agents of concern (i.e., responsive to positive controls),
not on convenience and familiarity.”
BPA as a SERM: Responses in Different Tissues and in Different Animal Models
A difference in the response of tissues to low doses of BPA is shown in articles that have been
published reporting that low doses of BPA do not stimulate a typical uterotrophic (increase in
uterine weight) response in mice and rats, while low-dose effects are observed in many other
endpoints. For example, effects on uterine weight have been observed at relatively high doses
of BPA (25 to 40 mg/kg/day), while changes in uterine gene activity occurred at lower doses
of 10 mg/kg/day in B6C3F1 mice and 0.8 mg/kg in transgenic ERIN mice [173-175]. In
prepubertal CD-1 mice, a dose of 100 mg/kg/day injected s.c. for 3 days was required to
stimulate an increase in uterine weight [176]; however, 5 mg/kg/day was sufficient to cause a
significant increase in the height of uterine epithelial cells in this strain, Similar findings
regarding the inability of low doses of BPA to stimulate a uterotrophic response in prepubertal
CD-1 mice were reported in another study [177], which, in comparison to the B6C3F1 mouse
data, provides further evidence for strain differences in sensitivity to BPA.
The prepubertal uterotrophic assay is thus a relatively insensitive endpoint for studies of BPA,
since the dose required to stimulate a uterotrophic response (one of the most commonly used
bioassays in toxicology to assess estrogenic activity), is markedly higher relative to doses that
cause significant effects in CD-1 mice in the prostate [10,16], testes [52], mammary glands
[79-81,88], and the brain and behavior [47,52,60,66]. All of these studies report significant
effects in response to developmental exposure of CD-1 mice to doses of BPA at and far below
the reference dose of 50 μg/kg/day (there are over 20 low-dose BPA studies published reporting
significant effects of BPA in CD-1 mice). As a specific example, when the magnitude of the
response to BPA in mammary gland and uterus are compared, the mammary gland appears to
be a more sensitive target for BPA action, but clearly, in utero exposure to low doses of BPA
does have lasting effects on the uterus in CD-1 mice [88].
Batch-to-Batch Variability in Feed: Impact on Low-Dose Endocrine Disruptor Research
The other major variable that has been implicated in contributing to discrepancies in the
outcome of experiments on low-dose effects of BPA is the type of feed used. Two workshops
on this issue were held in 2005 and 2006 to address this issue, and a manuscript reviewing the
conclusions from these workshops is being prepared. The consensus was that there is a critical
need for researchers to better understand the potential for components of commercial feed to
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impact research outcomes. Importantly, no one type of feed was deemed appropriate for the
many different types of research conducted with laboratory rats and mice, and both soy-based
and non-soy-based feeds were reported to contain variable amounts of estrogenic contaminants
that were not soy phytoestrogens [178]. The major concern was that feed manufacturers should
make every effort to reduce the batch-to-batch variability in feed components that can lead to
phenotypic variation in control animals.
Findings also presented at the workshops emphasized the critical importance of including
appropriate positive controls in experimental studies. With regard to BPA for example, the
inclusion of an appropriate positive control (based on experimental objectives and techniques,
such as route of administration) allows one to determine whether or not the test system has
been rendered insensitive to any estrogenic chemical or drug when drawing conclusions
concerning the potential safety of estrogenic chemicals such as BPA. A specific example was
provided by the finding of Thigpen et al. that a commonly used feed in toxicological studies,
PMI 5002, showed significant batch-to-batch variability in phytoestrogens that related to an
inability to detect significant effects of the potent estrogenic drug diethylstilbestrol (DES) with
some batches of this feed [19]. Some studies that reported finding no significant effects at low
doses of BPA [166,179] used PMI 5002 feed, raising concerns that effects of DES would not
have been found with the batches of this feed that were used. In fact, 0.1 μg/kg/day DES
(administered orally to pregnant CF-1 mice) was used as a positive control in one study
[179], and DES-exposed animals did not differ from negative controls on any outcome.
The Use of Positive Controls
The NTP panel commented in its 2001 report on the issue regarding: “a study in which the
positive control does not produce the expected positive response. The prudent course of action
in such cases may be to declare the study inadequate and repeat it, regardless of the experimental
outcome in the test groups” [172 p. 5-10]. The NTP panel went on to note that: “For those
studies that included DES exposure groups, those that showed an effect with BPA showed a
similar low-dose effect with DES (e.g. prostate and uterus enlargement in mice), while those
that showed no effect with BPA also found no effect with DES.” In many studies in which no
statistically significant effect of low doses of BPA were reported, no positive control was
included [155,156,159,160,166,180-185]. In particular, a positive control is the only way to
distinguish whether an experiment has been compromised by the presence of an estrogenic
contaminant in animal feed, water, or housing.
Three studies that concluded that there was no effect of low doses of BPA on the male [179,
186] or on both the male and female [109] reproductive system in mice suffered from a lack
of statistically significant effect of the positive control, DES. One study did report some effects
at a relatively high (15 μg/kg/day) dose of DES and no significant effects at any dose of BPA
[161]. As discussed previously, this high dose of DES is not a valid positive control in
experiments that fail to show effects of low doses of BPA. In summary, experiments reporting
only the absence of statistically significant effects of low doses of BPA that do not include a
positive control, or that fail to show significant effects of the positive control, cannot be
interpreted. Without positive control data obtained concurrently with the BPA data, there is no
way to determine the reason that significant effects were not observed for any test chemical.
There are now numerous studies that have been published showing similar effects of low doses
of BPA and DES, the most commonly used positive control for examining estrogenic effects
of BPA. For many outcomes, BPA has been reported to have the same efficacy but a 100-1000
– fold lower potency relative to DES [10,13-16,46,69,105,148,187-189].
There are some studies showing that, particularly for rapid responses mediated by receptors
associated with the cell membrane [190-192], BPA and DES (as well as E2) have equal potency.
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This subject is covered in detail in the report from the panel concerned with molecular
mechanisms. As discussed above, there is evidence that BPA is a SERM, and thus, while there
are studies showing similar effects of BPA and endogenous E2 or estrogenic drugs such as
DES, there are also studies showing qualitative differences in the responses of BPA and other
estrogens.
The Importance of Dose
There have been many published in vivo and in vitro mechanistic studies providing examples
of effects of BPA that are observed at a low dose, but are not observed at higher doses. This
type of dose-response relationship is known as an inverted-U-shaped curve. In toxicology, it
was long assumed that the only valid dose-related effect is a monotonic dose-response
relationship. However, as toxicologists have investigated more sub-lethal endpoints and more
extensive dose ranges, non-monotonic dose-response relationships have been encountered with
increasing frequency. The molecular basis for such findings is beginning to be understood in
terms of the stimulation and inhibition of unique sets of genes as one moves across the dose-
response curve [193,194]. These effects are likely to be mediated by different receptors [for
estrogens, ERα, ERβ, ERRγ and membrane-associated receptors [43,195,196], and both
positive and negative feedback effects on estrogen receptors and other receptors [6,7]]. Several
examples of unique effects of low doses of BPA have now been reported and are available for
review [45,46].
CONCLUSIONS AND LEVELS OF CONFIDENCE FOR DIFFERENT
OUTCOMES
1. Based on existing evidence, we are confident of the following
The criterion for an outcome being assessed as achieving this level (we are confident) is that
multiple independent studies have shown the same or similar outcomes.
Developmental effects on the brain and behavior—There is extensive evidence for
effects of exposure during critical periods to low doses of BPA on subsequent brain structure
and chemistry, receptors for hormones and neurotransmitters, and behavior. We can thus state
with confidence that low doses of BPA during development have persistent effects on brain
structure, function and behavior in rats and mice.
It is likely that due to species and strain differences, effects of BPA on specific brain structures,
functions and behaviors may show differences. However, some effects appear consistent. For
example, a number of studies have shown that expected differences between males and females
are not observed in animals exposed to BPA during development. In some experiments this
outcome has been due to males showing a more feminine phenotype and females showing a
more masculine phenotype [47,73], while in other experiments, the loss of the sex difference
was due to a measurable change in only one sex [197]. Further research may reveal whether
estrogenic effects dominate when low doses of BPA are administered and whether other effects
of BPA such as antiestrogenic or antiandrogenic effects are likely to be observed in the presence
of higher doses of BPA.
Developmental effects on the male reproductive tract—There is extensive evidence
that BPA impacts the reproductive system in male rats and mice, although there appear to be
species and strain differences in the sensitivity of specific outcomes to BPA. The evidence
supports an effect on the testes, with subsequent changes in testosterone secretion and sperm
production. Impacts on other reproductive structures have been reported in a number of
independent studies, including the epididymis and epididymal sperm, prostate, and seminal
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vesicles. These findings are consistent with effects of low doses of positive control chemicals,
such as DES and ethinylestradiol.
Developmental effects on enzyme activity, growth and metabolism—There is
extensive evidence for “programming” effects of BPA on subsequent activity of enzymes in
tissues and thus metabolic processes. An increase in postnatal growth rate due to developmental
exposure to low doses of BPA has been shown in many studies, and this finding is consistent
with the effect of developmental exposure to a low, but not high, dose of DES.
Adult effects on the male reproductive tract—There is a significant amount of evidence
that adult exposure to BPA has adverse consequences for testicular function in male rats and
mice. This is not surprising as estrogen, while essential for normal epididymis function, has
inhibitory effects on the brain-pituitary-gonadal axis in males, and it is well documented that
elevated E2 inhibits spermatogenesis and testicular testosterone secretion [1].
2. We consider the following to be likely but requiring confirmation
The criterion for achieving this level is that significant effects have been reported, but the
number of independent replications is limited. However, confidence in the findings is increased
by the plausibility of the results, based on mechanistic information available from other related
studies.
Developmental effects on the female reproductive tract—There is extensive
evidence for effects of BPA on development of the mammary gland. Studies in both rats and
mice have shown effects of developmental exposure to BPA on mammary gland morphology
that may predispose animals to develop cancer. These findings have not yet been repeated in
multiple independent laboratories.
Adult effects on the brain and behavior—There are a number of studies that have found
a variety of significant outcomes of adult exposure to BPA. Given the more extensive literature
showing developmental effects, there is no reason to expect that adult effects will not also
occur. However, effects in the adult may require higher doses of BPA exposure or longer
periods of BPA exposure.
An important unanswered question and research need is whether long-term adult exposure to
BPA may have adverse consequences, as has been recently found to be the case for hormone
replacement therapy (HRT), which is now thought to increase the risk for a number of diseases
[198]. The finding that BPA can stimulate proliferation of human cancer cells in the absence
of androgen is also cause for concern.
Adult effects on the female reproductive tract—While a number of studies have found
significant effects of BPA on the female reproductive system, not as much research has been
conducted as for the male reproductive system. For example, effects on meiosis in oocytes
need to be confirmed by additional studies. The recent report that maternal exposure to a very
low dose of BPA also disrupts meiosis in the embryonic oocyte during formation of the primary
follicles adds to our concern.
Adult effects on the immune system—There is extensive evidence that BPA modulates
both T helper 1 and T helper 2 cytokine production and alters antibody production.
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Abbreviations used
2F  
located in utero between female siblings
2M  
located in utero between male siblings
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ADI  
acceptable daily intake
AhR  
aryl hydrocarbon receptor
ARC  
arcuate nucleus
AVPV  
anteroventral periventricular preoptic area
BPA  
bisphenol A
Crl:CD(SD)  
Charles River Laboratories Sprague-Dawley rat strain
DES  
diethylstilbestrol
DRN  
dorsal raphe nucleus
EDC  
endocrine disrupting chemical
E2  
17β-estradiol
ERα  
estrogen receptor protein α
ERβ  
estrogen receptor protein β
Esr1  
estrogen receptor gene 1 (α)
Esr2  
estrogen receptor gene 2 (β)
GD  
gestation day
HRT  
hormone replacement therapy
IFN  
interferon
IgE  
immunoglobulin E
i.m.  
intramuscular
i.p.  
intraperitoneal
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LD50  
lethal dose, 50 % of population
LH  
luteinizing hormone
LoEC  
lowest effective concentration
LOAEL  
lowest observed adverse effect level
MPA  
medial preoptic area
NMU  
N-nitroso-N-methylurea
NTP  
National Toxicology Program
PND  
postnatal day
PIN  
prostate interepithelial neoplasia
p.o.  
oral adminisration
RAR  
retinoic acid receptor
RXR  
retinoid X receptor
SERM  
selective estrogen receptor modulator
s.c.  
subcutaneous
Th1  
T helper lymphocyte 1
Th2  
T helper lymphocyte 2
TH  
tyrosine hydroxylase
VMH  
ventromedial nucleus
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Figure 1.
Chemical structure of bisphenol A (BPA).
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Table 1
Physical, chemical, and acute toxicological properties of bisphenol A (BPA) [1,199].
Molecular formula (CH3)2C(C6H4OH)2
Molecular weight 228.29
Water solubility 120-300 mg/L
log kow 3.40
Melting point 150-155 °C
Boiling point 220 °C (4 mm Hg)
LD50, rat, oral* 3,300-4,240 mg/kg [199]
LD50, mouse, oral 2,500-5,200 mg/kg [1]
LD50, fish (Pimephales promelas), 96 hr 4.6 mg/L [1]
*
acute lethal dose, 50 % of population
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Table 2
Lack of effects reported in low-dose in vivo bisphenol A (BPA) research using the Charles River Laboratories
Sprague-Dawley (Crl:CD(SD)) rat strain.
Crl:CD(SD) RAT
STUDIES:
Effect No Effect
0 (0%) 13 (100%)
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Table 3
Published studies since 1997 (reviewed in detail in Table 4) that reported low-dose effects of bisphenol A (BPA)
in mice and rats resulting from exposure during development or during adulthood.
Number of Studies (Total number of studies, including citations in other
sections)
Observed adverse effects
51 (51) Altered brain physiology, structure, and behavior
22 (27) Altered male reproductive organs, including lower sperm production
17 (19) Altered female reproductive organs, including accelerated puberty
8 (22) Altered metabolism
7 (7) Altered immune system
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